Previous 10 | Next 10 |
2023-05-09 06:35:41 ET Elanco press release ( NYSE: ELAN ): Q1 Non-GAAP EPS of $0.45 beats by $0.16 . Revenue of $1.26B (+2.4% Y/Y) beats by $80M . Net leverage ratio of 5.4x Adjusted EBITDA Raising the bottom end of full year 2023 guidance ranges to reflec...
First Quarter 2023 Financial Results Revenue of $1,257 million, including an estimated $90-$110 million benefit from customer purchasing shifted from the second quarter into the first as a result of ERP system commercial ordering blackout period for legacy Bayer Animal Health products...
Targeted single-dose monoclonal antibody is the first and only treatment for devastating dog disease Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Department of Agriculture (USDA) has provided a conditional license for the first Canine Parvovirus Monoclonal Ant...
California Dairies, Inc. and DSM Venturing Complete Strategic Investment in Athian PR Newswire Athian's livestock carbon credit marketplace completes latest round of funding thanks to the investment by California Dairies, Inc. and DSM Venturing INDIANAPOLIS ,...
2023-04-28 14:18:29 ET Summary Elanco Animal Health finally saw its stock price decline steep after it was trading for extremely high valuation multiples for a long time. Additionally, Elanco Animal Health still has extremely high debt levels. Results for fiscal 2022 were not ...
2023-04-24 22:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2023 financial results on Tuesday, May 9, 2023. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference call...
2023-04-15 06:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-13 15:39:47 ET Summary Today, we provide you the first quarter update in our recurring series based on firms that have enjoyed unusual insider interest during the first quarter of the year. We stand behind our belief that insiders supply the market with high-quality invest...
2023-04-13 13:30:22 ET Dechra Pharmaceuticals PLC ( OTCPK:DPHAY ) ADRs soared 45% after the company confirmed it was in talks with EQT in regard to a potential all-cash 4.63 billion pound ($5.8 billion) offer the UK-based veterinary pharmaceuticals firm. Dechra ( OTCPK:DPHAY...
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Feeding dairy cows Bovaer® (3-NOP), Elanco's newest feed ingredient , provides a scalable and credible way for dairy farmers to benefit from being good stewards of the environment by being financially rewarded for implementing on-farm sustaina...
Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement PR Newswire GREENFIELD, Ind. , July 18, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2024 financial results on ...
SAN FRANCISCO, CA / ACCESSWIRE / July 17, 2024 / Hagens Berman urges Elanco Animal Health Incorporated (NYSE:ELAN) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com 844-916-0895 ...